IRCT20150107020592N26 IRCT 2020-06-15 Masih Daneshvari Hospital Favipiravir effectiveness in patients undergoing COVID19 Acute respiratory distress syndrome (ARDS) Favipiravir effectiveness in patients undergoing COVID19 Acute respiratory distress syndrome (ARDS) 2020-03-20 anticipated 20 Complete https://irct.ir/trial/48746 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. 3 covid positive. Intervention group:Patients with a pao2 to fio2 ratio of less than 300 and who have bilateral infiltration in the chest x ray were included in the study. On the first day, 3200 mg for first day and 1600 mg of the drug were given twice daily in the morning and evening for seven days. Chest x ray and symptoms of the disease, including fever and headache, were recorded. Yes - There is a plan to make this available What will be shared: All patient information can be published after deleting the name When: It will take a month from the time of application To whom: All professors of medical universities in the country Conditions: Help advance science Where to obtain: professor hashemian in masih daneshvari hospital How to obtain: one month Comments: